Atropine Sulfate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Jan 1, 2012. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1630-10
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)
Initial Posting
Jan 1, 2012

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.